Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farhad Ravandi

Showing results (1-10 of 962) with videos related to

Pageof 97
Sort By:
Oncology (Williston Park, N.Y.)|August 31, 2011
Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapyFarhad Ravandi
British Journal of Haematology|September 14, 2011
Primary refractory acute myeloid leukaemia - in search of better definitions and therapiesFarhad Ravandi
Haematologica|April 2, 2011
Therapy-related acute promyelocytic leukemiaFarhad Ravandi
Leukemia & Lymphoma|June 27, 2009
Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapyFarhad Ravandi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapyFarhad Ravandi
Current Hematologic Malignancy Reports|March 18, 2014
Incorporating tyrosine kinase inhibitors into treatment regimens for AML and ALL: is there a right or wrong way?Farhad Ravandi
Frontiers in Oncology|October 24, 2012
Acute myeloid leukemia as a model for cancer therapyFarhad Ravandi
Best Practice & Research. Clinical Haematology|December 6, 2020
Antibody-based targeted therapiesFarhad Ravandi
Leukemia Research|September 19, 2013
"It's effective therapy, stupid!"Farhad Ravandi
Leukemia & Lymphoma|August 5, 2006
Treatment of acute myeloid leukemia in older adults: time to reflect?Farhad Ravandi
Pageof 97

Showing results (1-10 of 962) with videos related to

Sort By:
Pageof 97
Oncology (Williston Park, N.Y.)|August 31, 2011
Acute promyelocytic leukemia can be treated successfully without cytotoxic chemotherapyFarhad Ravandi
British Journal of Haematology|September 14, 2011
Primary refractory acute myeloid leukaemia - in search of better definitions and therapiesFarhad Ravandi
Haematologica|April 2, 2011
Therapy-related acute promyelocytic leukemiaFarhad Ravandi
Leukemia & Lymphoma|June 27, 2009
Therapy-related acute promyelocytic leukemia: further insights into the molecular basis of the disease and showing the way forward in therapyFarhad Ravandi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Gemtuzumab ozogamicin: one size does not fit all--the case for personalized therapyFarhad Ravandi
Current Hematologic Malignancy Reports|March 18, 2014
Incorporating tyrosine kinase inhibitors into treatment regimens for AML and ALL: is there a right or wrong way?Farhad Ravandi
Frontiers in Oncology|October 24, 2012
Acute myeloid leukemia as a model for cancer therapyFarhad Ravandi
Best Practice & Research. Clinical Haematology|December 6, 2020
Antibody-based targeted therapiesFarhad Ravandi
Leukemia Research|September 19, 2013
"It's effective therapy, stupid!"Farhad Ravandi
Leukemia & Lymphoma|August 5, 2006
Treatment of acute myeloid leukemia in older adults: time to reflect?Farhad Ravandi
Pageof 97